Use of platelet-rich plasma and bone marrow-derived mesenchymal stem cells in foot and ankle surgery

Techniques in Foot and Ankle Surgery

Volumn 6, Issue 2, 2007, Pages 89-94

  Barnett Jr , Michael D ^a,c   Pomeroy, Gregory C ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Portland Orthoped Foot Ankle Ctr   (United States)

^c MIAMI VALLEY HOSPITAL   (United States)

Author keywords

Autologous mesenchymal stem cells; Platelet concentrate; Platelet rich plasma

Indexed keywords

ANKLE FRACTURE; ANKLE SURGERY; BONE GRAFT; BONE TRANSPLANTATION; CELL PROLIFERATION; COST EFFECTIVENESS ANALYSIS; FOOT FRACTURE; FOOT SURGERY; FRACTURE HEALING; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THROMBOCYTE RICH PLASMA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 34249988533     PISSN: 15360644     EISSN: 15381943     Source Type: Journal    
DOI: 10.1097/btf.0b013e33180621290     Document Type: Review

References (42)

1. Fleming JE, Muschler GF. The cell biology of bone tissue engineering. Semin Arthroplasty. 2002;13:143-157.
2. Gazdag AR, Lane JM, Glaser D, et al. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg. 1995;3:1-8.
3. Khan S, Tomin E, Lane JM. Clinical applications of bone graft substitutes. Orthop Clin North Am. 2000;31:389-398.
4. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114:1502-1508.
5. Slater M, Patava J, Kingham K, et al. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995;13:655-663.
6. Trippel SB. Growth factors as therapeutic agents. Instr Course Lect. 1997;46:473-476.
7. Bolander ME. Regulation of fracture repair and synthesis of matrix macromolecules. In: Brighton CT, Friedlander GE, Lane JM, eds. Bone Formation and Repair. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1994:185-196.
8. Arinzeh TL. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications. Foot Ankle Clinics. 2005;10:651-665.
9. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997;79:1699-1709.
10. Soltan M, Smiler DG, Gailani F. A new "platinum" standard for bone grafting: autogenous stem cells. Implant Dent. 2005;14:322-325.
11. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res. April 1995;313:8-18.
12. Block JE. The role and effectiveness of bone marrow in osseous regeneration. Med Hypotheses. 2005;65:740-747.
13. Strates BS, Tiedeman JJ. Contribution of osteoinductive and osteoconductive properties of demineralized bone matrix to skeletal repair. Eur J Exp Musculoskel Res. 1993;2:61-67.
14. Floryan KM, Berghoff WJ. Intraoperative use of autologous platelet-rich and platelet-poor plasma for orthopedic surgery patients. AORN J. 2004;80:668-674.
15. DePuy Symphony™ PCS Product Manual. Warsaw, IN: DePuy.
16. Fleming JE, Muschler GF. The cell biology of bone tissue engineering. Semin Arthroplasty. 2002;13:143-157.
17. DePuy Cellect™ Product Manual. Warsaw, IN: DePuy.
18. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997;79:1699-1709.
19. Gupta AR, Shah NR, Patel TC, et al. Perioperative and long-term complications of iliac crest bone graft harvesting for spinal surgery: a quantitative review of the literature. Int Med J. 2001;8:163-166.
20. Ksander GA, Sawamura SJ, Ogawa Y, et al. The effect of platelet releasate on wound healing in animal models. J Am Acad Dermatol. 1990;22(pt 1):781-791.
21. Siebrecht MA, De Rooij PP, Arm DM, et al. Platelet concentrate increases bone ingrowth into porous hydroxyapatite. Orthopedics. 2002;25:169-172.
22. Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand. 2004;75:93-99.
23. Kim ES, Park EJ, Choung PH. Platelet concentration and its effect on bone formation in calvarial defects: an experimental study in rabbits. J Prosthet Dent. 2001;86:428-433.
24. Jodczyk KJ, Bankowski E, Borys A. Stimulatory effect of platelet-breakdown products on muscle regeneration. Zentralbl Allg Pathol. 1986;131:357-361.
25. Miyashita T, Kuro M. Effects of autologous fresh platelet concentrate on haemostasis in cardiac reoperations. Platelets. 2001;12:248-253.
26. Trowbridge CC, Stammers AH, Woods E, et al. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol. 2005;37:381-386.
27. Babbush CA, Kevy SV, Jacobson MS. An in vitro and in vivo evaluation of autologous platelet concentrate in oral reconstruction. Implant Dent. 2003;12:24-34.
28. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107:229-237.
29. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spinal fusion. Bone. 1999;25:47S-50S.
30. Weiner BK, Walker M. Efficacy of autologous growth factors in lumbar intertransverse fusions. Spine. 2003;28:1968-1971.
31. Barrow CR, Pomeroy GC. Enhancement of syndesmotic fusion rates in total ankle arthroplasty with the use of autologous platelet concentrate. Foot Ankle Int. 2005;26:458-461.
32. Coetzee JC, Pomeroy GC, Watts JD, et al. The use of autologous concentrated growth factors to promote syndesmosis fusion in the Agility total ankle replacement. A preliminary study. Foot Ankle Int. 2005;26:840-846.
33. Bibbo C, Bono CM, Lin SS. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv. 2005;14:17-22.
34. Wang T, Dang G, Guo Z, et al. Evaluation of autologous bone marrow mesenchymal stem cell-calcium phosphate ceramic composite for lumbar fusion in rhesus monkey interbody fusion model. Tissue Eng. 2005;11:1159-1167.
35. Lindholm TS, Ragni P, Lindholm TC. Response of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbits. Clin Orthop Relat Res. May 1988;230:296-302.
36. Lindholm TS, Nilsson OS, Lindholm TC. Extraskeletal and intraskeletal new bone formation induced by demineralized bone matrix combined with bone marrow cells. Clin Orthop Relat Res. November-December 1982;171:251-255.
37. Tiedeman JJ, Connolly JF, Strates BS, et al. Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. Clin Orthop Relat Res. July 1991;268:294-302.
38. Romih M, Delecrin J, Heymann D, et al. The vertebral interbody grafting site's low concentration in osteogenic progenitors can greatly benefit from addition of iliac crest bone marrow. Eur J Spine. 2005;14:645-648.
39. Hernigou P, Poignard A, Beaujean F, et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005;87:1430-1437.
40. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res. April 1995;313:8-18.
41. Docquier PL, Delloye C. Treatment of aneurysmal bone cysts by introduction of demineralized bone and autogenous bone marrow. J Bone Joint Surg Am. 2005;87:2253-2258.
42. Sharp JG, Murphy BO, Jackson JD, et al. Promises and pitfalls of stem cell therapy for promotion of bone healing. Clin Orthop Relat Res. June 2005;435:52-61.